Orion Corporation: Managers’ transactions – Kari Jussi Aho
ORION CORPORATION MANAGERS’ TRANSACTIONS 25 AUGUST 2021 at 12.00 EEST Orion Corporation: Managers’ transactions – Kari Jussi Aho Orion...
News
Bavarian Nordic Announces First Half 2021 Results
COPENHAGEN, Denmark, August 25, 2021 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress...
argenx Announces Validation of European Marketing Authorization Application for Efgartigimod in Generalized Myasthenia Gravis
Validation initiates formal evaluation of application which started on August 19, 2021; decision expected mid-2022If approved, efgartigimod will be the...
IBA Reports Half Year 2021 Results
25% SALES GROWTH AND STRONG IMPROVEMENT IN REBIT LINKED TO INCREASED ACTIVITY AND ACCELERATED BACKLOG CONVERSION STRONG BALANCE SHEET WITH...
HEXO Corp. Closes US$144.8 Million Underwritten Public Offering
OTTAWA, Aug. 24, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NASDAQ: HEXO) today announced the...
VitalHub Increases Q2 2021 Revenue to $5.8M While Continuing to Improve on Financial Metrics Across the Business
TORONTO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed...
ACR Webinar: Reproductive Health & Rheumatic Disease
Atlanta, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Rheumatic diseases are lifelong conditions that affect over 54 million Americans, often during...
ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer
ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer Webinar on Wednesday, September 1st @ 10am ET/4pm CET...
Progenity Announces Closing of $40 Million Underwritten Public Offering
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the...
RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021
ALISO VIEJO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it...
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who...
Applied Molecular Transport Appoints Holly Schachner, M.D. to its Board of Directors
SOUTH SAN FRANCISCO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical...
Mydecine Innovations Group Announces Mailing of Management Information Circular and Provides Update on Spin-Out of U.S. Cannabis Assets
DENVER, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), is...
Coloplast SenSura® Mio is Extended Wear in the US
Ostomates now have access to a new option, as a recent patient survey showed that SenSura Mio reduces leakage while...
Leveljump Q2 Earnings and Results; Record Quarter with 40% Revenue Increase Year over Year and Increased Gross Margin
Toronto, Ontario--(Newsfile Corp. - August 25, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the...
VIVO Cannabis(TM) Provides Strategic Update for a Medical Cannabis Focus
Toronto, Ontario--(Newsfile Corp. - August 25, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading...
Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET
Vancouver, British Columbia--(Newsfile Corp. - August 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it...
NextGen® Mobile Enables Neighborhood Health to Deliver Care to Nashville’s Homeless Population
Healthcare Providers Extend Their Reach and Improve Outcomes by Using NextGen Healthcare’s Mobile Solution to Access Electronic Health Records in...
NeonMind Announces DTC Eligibility
VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug...
AlzeCure Publishes its Interim Report for January – June 2021
STOCKHOLM, SE / ACCESSWIRE / August 25, 2021 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today...